z-logo
Premium
Ex‐vivo expanded baboon CD4 + CD25 Hi Treg cells suppress baboon anti‐pig T and B cell immune response
Author(s) -
Singh Avneesh K.,
Seavey Caleb N.,
Horvath Keith A.,
Mohiuddin Muhammad M.
Publication year - 2012
Publication title -
xenotransplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.052
H-Index - 61
eISSN - 1399-3089
pISSN - 0908-665X
DOI - 10.1111/j.1399-3089.2012.00697.x
Subject(s) - il 2 receptor , ex vivo , foxp3 , biology , immune system , baboon , cd28 , t cell , immunology , regulatory t cell , cytotoxic t cell , peripheral blood mononuclear cell , interleukin 21 , microbiology and biotechnology , in vivo , in vitro , endocrinology , biochemistry
Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4 +  CD25 Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley & Sons A/S. Abstract: Background:  CD4 +  CD25 +  FoxP3 + regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4 +  CD25 + T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods:  Naturally occurring baboon CD4 +  CD25 + regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4 + T cells cultured in the presence of rapamycin (0.1–10 n m ). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results:  The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4 +  CD25 +  FoxP3 + Treg cells from CD4 + cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4 +  CD25 Neg cells however induced vigorous proliferation. Conclusion:  Ex‐vivo expanded CD4 +  CD25 +  FoxP3 + Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex‐vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here